Tregs expressing TIGIT supressed Th1 and Th17 cell responses (98) and signalling through TIGIT on functionally defective Tregs from patients with multiple sclerosis restored suppressive function (99), highlighting the potential of TIGIT-targeting. Here, TIGIT is linked to multiple sclerosis.